Gail J. Roboz

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial”.

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial

Journal of Hematology & Oncology(2021)10.1186/s13045-020-01004-y

N/A

1.9DataRank · unranked

86 citations

Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Tadeusz Robak +14 more

Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101

Blood Advances(2022)10.1182/bloodadvances.2021006872

N/A

1.1DataRank · unranked

40 citations

Heidi D. Klepin, Elizabeth Storrick, Brittny Major, Jennifer Le‐Rademacher, Martha Wadleigh +4 more

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality

Cancer(2024)10.1002/cncr.35455

N/A

0.425DataRank · unranked

16 citations

Ying Zhou, Justin Grenet, Samuel K. Handelman, Cynthia Crispino, Laura N. Tarbay +20 more

A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia

Blood Neoplasia(2025)10.1016/j.bneo.2025.100126

N/A

0.330DataRank · unranked

8 citations

Gabriel N. Mannis, Yazan F. Madanat, Brian A. Jonas, Neil Dunavin, Gail J. Roboz +15 more

Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999

Blood Cancer Journal(2022)10.1038/s41408-022-00736-z

N/A

0.104DataRank · unranked

1 citations

Kenneth Seier, Yaseswini Neelamraju, Duane C. Hassane, Timour Baslan, Daniel T. Gildea +21 more

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101072

N/A

0DataRank · unranked

18 citations

Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner +37 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)

Blood Advances(2024)10.1182/bloodadvances.2024014367

N/A

0DataRank · unranked

2 citations

Minji Lee, Olivia Bobek, Jennifer Le‐Rademacher, Sumithra J. Mandrekar, Gail J. Roboz +4 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

Wild-type p53 overexpression in NPM1-mutated acute myeloid leukemia: potential implications for disease biology and therapy response

Haematologica(2025)10.3324/haematol.2025.288054

N/A

0DataRank · unranked

0 citations

Siarhei Dzedzik, Ashley S. Kleinman, Christopher R. Chin, Cem Meydan, Itzel Valencia +10 more

BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells

Blood(2020)10.1182/blood.2019001745

N/A

0DataRank · unranked

39 citations

Hongliang Zong, Cem Meydan, Sarah Wyman, Bas J. Wouters, Mayumi Sugita +11 more

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Blood(2021)10.1182/blood.2021013626

N/A

0DataRank · unranked

738 citations

Sylvie Freeman, Gert J. Ossenkoppele, Francesco Buccisano, Christopher S. Hourigan, Lok Lam Ngai +40 more

Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations

Leukemia(2021)10.1038/s41375-021-01230-4

N/A

0DataRank · unranked

80 citations

Yishai Ofran, Agnieszka Wierzbowska, Farhad Ravandi, Christopher S. Hourigan, Lok Lam Ngai +5 more

Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Blood(2022)10.1182/blood.2022015832

N/A

0DataRank · unranked

36 citations

Pierre Fenaux, Marco Gobbi, Jiřı́ Mayer, Gail J. Roboz, Jürgen Krauter +21 more

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel

American Journal of Hematology(2023)10.1002/ajh.27087

N/A

0DataRank · unranked

24 citations

Jacqueline Cloos, Francesco Buccisano, Richard Dillon, Konstanze Döhner, Sylvie Freeman +12 more